Page last updated: 2024-10-31

mitoxantrone and Anasarca

mitoxantrone has been researched along with Anasarca in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"More recently, a number of cases of panniculitis and subcutaneous inflammatory oedema have been described."1.37[Severe skin reaction with mucous membrane inflammation during MINE chemotherapy]. ( Camus, M; Guillet, G; Hainaut-Wierzbicka, E; Levillain, P; Lopez, L; Saulnier, JP, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camus, M1
Hainaut-Wierzbicka, E1
Levillain, P1
Saulnier, JP1
Lopez, L1
Guillet, G1
Valencak, J1
Troch, M1
Raderer, M1

Other Studies

2 other studies available for mitoxantrone and Anasarca

ArticleYear
[Severe skin reaction with mucous membrane inflammation during MINE chemotherapy].
    Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Edema; Etoposide; Female

2011
Cutaneous recall phenomenon at the site of previous doxorubicin extravasation after second-line chemotherapy.
    Journal of the National Cancer Institute, 2007, Jan-17, Volume: 99, Issue:2

    Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Edem

2007